Tumor Characteristics, Genetics, Management, and the Risk of Metastasis in Uveal Melanoma

REFERENCES

• Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology 2003;110 (5):956–961.
   PubMed Web of Science ®Google Scholar
• Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E. Incidence of uveal melanoma in Europe. Ophthalmology 2007;114(12):2309–2315.
   PubMed Web of Science ®Google Scholar
• Cerbone L, Van Ginderdeuren R, Van Den Oord J, Fieuws S, Spileers W, Van Eenoo L, Wozniak A, Sternberg CN, Schöffski P. Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal disease. Oncology (Switzerland) 2014;86(3185–189.
   Google Scholar
• Singh AD, Turell ME, Topham AK. Uveal melanoma: Trends in incidence, treatment, and survival. Ophthalmology 2011;118(9):1881–1885.
   PubMed Web of Science ®Google Scholar
• Singh AD, Topham A. Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology 2003;110 (5):962–965.
   PubMed Web of Science ®Google Scholar
• Bishop KD, Olszewski AJ. Epidemiology and survival outcomes of ocular and mucosal melanomas: A population-based analysis. International Journal of Cancer 2014;134(12):2961–2971.
   PubMed Web of Science ®Google Scholar
• Burr JM, Mitry E, Rachet B, Coleman MP. Survival from uveal melanoma in England and Wales 1986 to 2001. Ophthalmic Epidemiology 2007;14(1):3–8.
   PubMed Web of Science ®Google Scholar
• Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz J-M, Paci E. Survival in patients with uveal melanoma in Europe. Archives of Ophthalmology 2008;126 (10):1413–1418.
   PubMedGoogle Scholar
• Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Investigative Ophthalmology & Visual Science 2003;44(11):4651–4659.
   PubMed Web of Science ®Google Scholar
• Yonekawa Y, Kim IK. Epidemiology and management of uveal melanoma. Hematology/Oncology Clinics of North America 2012;26(6):1170–1184.
   Google Scholar
• Singh AD. Uveal melanoma: implications of tumor doubling time. Ophthalmology 2001;108(5):829–31.
   PubMed Web of Science ®Google Scholar
• Ah-Fat FG, Damato BE. Delays in the diagnosis of uveal melanoma and effect on treatment. Eye (London, England) 1998;12 ( Pt 5)( 0):781–782.
   PubMed Web of Science ®Google Scholar
• Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: An evaluation of 2384 patients. Ophthalmology 2012;119(8):1582–1589.
   PubMed Web of Science ®Google Scholar
• Bove R, Char DH. Nondiagnosed uveal melanomas. Ophthalmology 2004;111(3):554–557.
   PubMed Web of Science ®Google Scholar
• Shields CL. The Coms randomized trial of iodine 125 brachytherapy for choroidal melanoma. Evidence-Based Eye Care 2004;5(3):164–166.
   Google Scholar
• Hawkins BS. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV: Ten-year mortality findings and prognostic factors, COMS report number 24. Am J Ophthalmol 2004;138(6):936–51.
   PubMed Web of Science ®Google Scholar
• Grossniklaus HE. Progression of ocular melanoma metastasis to the liver: The 2012 Zimmerman lecture. JAMA Ophthalmol 2013;131(4):462–9.
   PubMed Web of Science ®Google Scholar
• Yonekawa Y, Kim IK. Epidemiology and management of uveal melanoma. Hematol Oncol Clin North Am 2012;26 (6):1169–84.
   PubMed Web of Science ®Google Scholar
• Collaborative Ocular Melanoma Study. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V: Twelve-year mortality rates and prognostic factors, COMS report No. 28. Arch Ophthalmol 2006;124 (12):1684–93.
   Google Scholar
• Schmittel A, Bechrakis NE, Martus P, Mutlu D, Scheibenbogen C, Bornfeld N, Foerster MH, Thiel E, Keilholz U. Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma. European Journal of Cancer 2004;40 (16):2389–2395.
   PubMed Web of Science ®Google Scholar
• Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Research 2001;11(3):255–263.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983;101(12):1894–9.
   PubMedGoogle Scholar
• Kujala E, Damato B, Coupland SE, Desjardins L, Bechrakis NE, Grange JD, Kivela T. Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol 2013;31 (22):2825–31.
   PubMed Web of Science ®Google Scholar
• Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 1992;110(2):245–50.
   Google Scholar
• Shields CL, Furuta M, Thangappan A, Nagori S, Mashayekhi A, Lally DR, Kelly CC, Rudich DS, Nagori AV, Wakade OA, Mehta S, Forte L, Long A, Dellacava EF, Kaplan B, Shields JA. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol 2009;127(8):989–98.
   PubMedGoogle Scholar
• Shields CL, Kaliki S, Furuta M, Fulco E, Alarcon C, Shields JA. American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients. Ophthalmology 2013;120(10):2066–2071.
   PubMed Web of Science ®Google Scholar
• McLean MJ, Foster WD, Zimmerman LE. Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol 1977;95(1):48–58.
   PubMedGoogle Scholar
• Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, Gruman LM. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993;100(9):1389–98.
   Google Scholar
• Gill HS, Char DH. Uveal melanoma prognostication: From lesion size and cell type to molecular class. Canadian Journal of Ophthalmology 2012;47(3):246–253.
   PubMed Web of Science ®Google Scholar
• Harbour JW. The genetics of uveal melanoma: An emerging framework for targeted therapy. Pigment Cell and Melanoma Research 2012;25(2):171–181.
   PubMed Web of Science ®Google Scholar
• Klebe S, Driml J, Nasu M, Pastorino S, Zangiabadi A, Henderson D, Carbone M. BAP1 hereditary cancer predisposition syndrome: A case report and review of literature. Biomark Res 2015;3:14.
   Google Scholar
• Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010;330(6009):1410–3.
   PubMed Web of Science ®Google Scholar
• Onken MD, Worley LA, Person E, Char DH, Bowcock AM, Harbour JW. Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res 2007;13(10):2923–7.
   PubMed Web of Science ®Google Scholar
• Aalto Y, Eriksson L, Seregard S, Larsson O, Knuutila S. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 2001;42(2):313–7.
   PubMed Web of Science ®Google Scholar
• Sisley K, Rennie IG, Parsons MA, Jacques R, Hammond DW, Bell SM, Potter AM, Rees RC. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 1997;19(1):22–8.
   PubMed Web of Science ®Google Scholar
• Onken MD, Worley LA, Harbour JW. A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis. Clin Cancer Res 2008;14 (12):3737–45.
   PubMed Web of Science ®Google Scholar
• Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O'Brien J, Bastian BC. Mutations in GNA11 in uveal melanoma. N Engl J Med 2010;363(23):2191–9.
   PubMed Web of Science ®Google Scholar
• Daniels AB, Lee JE, MacConaill LE, Palescandolo E, Van Hummelen P, Adams SM, DeAngelis MM, Hahn WC, Gragoudas ES, Harbour JW, Garraway LA, Kim IK. High throughput mass spectrometry-based mutation profiling of primary uveal melanoma. Invest Ophthalmol Vis Sci 2012;53(11):6991–6.
   PubMed Web of Science ®Google Scholar
• Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS, Bastian BC. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009;457 (7229):599–602.
   PubMed Web of Science ®Google Scholar
• Field MG, Harbour JW. Recent developments in prognostic and predictive testing in uveal melanoma. Current Opinion in Ophthalmology 2014;25(3):234–9.
   PubMed Web of Science ®Google Scholar
• Chang SH, Worley LA, Onken MD, Harbour JW. Prognostic biomarkers in uveal melanoma: Evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res 2008;18(3):191–200.
   PubMed Web of Science ®Google Scholar
• Onken MD, Ehlers JP, Worley La, Makita J, Yokota Y, Harbour JW. Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Research 2006;66(9):4602–4609.
   PubMed Web of Science ®Google Scholar
• Damato B, Dopierala J, Klaasen A, van Dijk M, Sibbring J, Coupland SE. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci 2009;50(7):3048–55.
   PubMed Web of Science ®Google Scholar
• Vaarwater J, van den Bosch T, Mensink HW, van Kempen C, Verdijk RM, Naus NC, Paridaens D, Bruggenwirth HT, Kilic E, de Klein A. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma. Melanoma Res 2012;22(1):30–7.
   PubMed Web of Science ®Google Scholar
• Damato B, Dopierala JA, Coupland SE. Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 2010;16(24):6083–92.
   PubMed Web of Science ®Google Scholar